Ventricular arrhythmias after precordial electric shock.
D001161:Arteriosclerosis / Q000628:therapy; D001919:Bradycardia / Q000209:etiology*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock / Q000009:adverse effects*; D005260:Female; D006330:Heart Defects, Congenital / Q000628:therapy; D006331:Heart Diseases / Q000628:therapy; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000628:therapy; D010493:Pericarditis / Q000628:therapy; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000628:therapy; D013312:Stress, Physiological; D013610:Tachycardia / Q000209:etiology*; D014693:Ventricular Fibrillation / Q000209:etiology*
D004071:Digitalis Glycosides; D011802:Quinidine; D011342:Procainamide